HEPCINAT 400MG TABLET contains Sofosbuvir which belongs to the group of medicines called Antiviral agents. HEPCINAT 400MG TABLET is used with Ribavirin/ Peginterferon alfa and ribavirin (antiviral medicines) to manage hepatitis C viral infection in adults and children (aged 3 years/above), which is a type of viral infection that infects the liver.
HEPCINAT 400MG TABLET is not recommended for use in patients allergic to Sofosbuvir.
Before taking HEPCINAT 400MG TABLET, inform your doctor if you have a history of hepatitis B virus infection, and/or suffer from diabetes, heart problems, kidney problems, and/or other liver problems.
HEPCINAT 400MG TABLET is not recommended for use during pregnancy and in women planning for pregnancy since Ribavirin (antiviral medicine used with Sofosbuvir) may cause harm to the unborn baby. Women of childbearing potential should use effective contraceptive measures to avoid getting pregnant and undergo a routine pregnancy test during and after management (for 9 months). If accidental pregnancy occurs, then it should be informed to the doctor immediately.
The medicine is also not recommended for use in breastfeeding women since it is not known whether the medicine may pass through breast milk.
HEPCINAT 400MG TABLET is not recommended for use in children (aged below 3 years) and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking HEPCINAT 400MG TABLET are fever, chills, diarrhoea, nausea, vomiting, dizziness, feeling depressed/anxious/agitated, and/or headache. Consult with your doctor if any of these symptoms worsen.
No content available
